EBS - Emergent BioSolutions up 5% after institutional investor hedge fund buys
2023-03-09 08:10:06 ET
- Shares of Emergent BioSolutions ( NYSE: EBS ) are up 5% in premarket trading after a number of institutional investors and hedge funds increased their holdings.
- Eagle Asset Management Inc. owns 160,153 shares with a value of $3.361M following a purchase of an additional 61,422 shares.
- UBS Group boosted its position by 22% and now own shares worth $1.821M.
- In Q3 2022, Great-West Life Assurance of Canada purchased a new stake in Emergent ( EBS ) with a value of $1.163M.
- About 80% of the Emergent ( EBS ) stock is owned by institutional investors and hedge funds, according to MarketBeat .
- Read why Seeking Alpha contributor Singular Research recently upgraded its rating on Emergent ( EBS ) to buy.
For further details see:
Emergent BioSolutions up 5% after institutional investor, hedge fund buys